The retina and ear are particularly good candidates for gene therapy. They are relatively easy to access surgically for vector delivery, allowing for localised treatment and reduced vector ...
The gene augmentation product was a recombinant AAV8 vector expected to express AIPL1 in both rods and cones. The better-seeing eye of each of the four children (age range 1–3 years; two males and two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback